Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb–drug interactions in antiviral therapy

[1]  N. V. Polekhina,et al.  Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia , 2020, Current medical research and opinion.

[2]  A. Zeiher,et al.  Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry , 2020, Clinical Research in Cardiology.

[3]  Bo Han,et al.  Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection , 2020, Journal of Global Antimicrobial Resistance.

[4]  A. Boretti,et al.  Use of Ultraviolet Blood Irradiation Against Viral Infections , 2020, Clinical Reviews in Allergy & Immunology.

[5]  N. Zhang,et al.  Design, synthesis and biological evaluation of indanone-chalcone hybrids as potent and selective hCES2A inhibitors. , 2020, European journal of medicinal chemistry.

[6]  Seung‐Woo Cho,et al.  Quasi-Irreversible Inhibition of CYP2D6 by Berberine , 2020, Pharmaceutics.

[7]  D. Duan,et al.  Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives , 2020, Acta Pharmacologica Sinica.

[8]  S. Agarwal,et al.  Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications , 2020, Cardiovascular Drugs and Therapy.

[9]  A. Alam,et al.  Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past , 2020, Frontiers in Immunology.

[10]  Yimin Li,et al.  Clinical Practice Guideline on Treating Influenza in Adult Patients with Chinese Patent Medicines. , 2020, Pharmacological research.

[11]  Guangbo Ge,et al.  Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  K. Kalantar-Zadeh,et al.  Pharmaco-Immunomodulatory Therapy in COVID-19 , 2020, Drugs.

[13]  Yuqiao Shen,et al.  Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China , 2020, Frontiers in Pharmacology.

[14]  Liang Liang,et al.  Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment , 2020, Biomedicine & Pharmacotherapy.

[15]  Li Yang,et al.  Overview of therapeutic drug research for COVID-19 in China , 2020, Acta Pharmacologica Sinica.

[16]  Zi-feng Yang,et al.  Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model , 2020, Evidence-based complementary and alternative medicine : eCAM.

[17]  N. Brunetti,et al.  The thromboembolism in COVID-19: the unsolved problem. , 2020, Panminerva medica.

[18]  Zhengyin Yan,et al.  NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition , 2020, Drug Metabolism and Disposition.

[19]  Li Ma,et al.  Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019 , 2020, Medicine.

[20]  J. Rhee,et al.  Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy , 2020, International Journal of Infectious Diseases.

[21]  Junshan Ruan,et al.  Quadruple therapy for asymptomatic COVID-19 infection patients , 2020, Expert review of anti-infective therapy.

[22]  Guangbo Ge,et al.  Pharmacokinetic interaction between a Chinese herbal formula Huosu Yangwei oral liquid and apatinib in vitro and in vivo , 2020, The Journal of pharmacy and pharmacology.

[23]  Asha B. Thomas,et al.  Herb–drug interaction studies of herbs used in treatment of cardiovascular disorders—A narrative review of preclinical and clinical studies , 2020, Phytotherapy research : PTR.

[24]  Guangbo Ge.  Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system. , 2019, Chinese journal of natural medicines.

[25]  Guangbo Ge,et al.  Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus. , 2019, Chinese journal of natural medicines.

[26]  Guangbo Ge,et al.  Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening. , 2019, International journal of biological macromolecules.

[27]  S. Jianmongkol,et al.  Rhinacanthin-C Mediated Herb-Drug Interactions with Drug Transporters and Phase I Drug-Metabolizing Enzymes , 2019, Drug Metabolism and Disposition.

[28]  M. Finel,et al.  Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism. , 2019, Chemico-biological interactions.

[29]  J. Chen,et al.  Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1. , 2018, International journal of biological macromolecules.

[30]  Lars Kaderali,et al.  Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling , 2018, Front. Microbiol..

[31]  C. Hidalgo-Tenorio,et al.  High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial , 2018, PloS one.

[32]  H. Tallima,et al.  Arachidonic acid: Physiological roles and potential health benefits – A review , 2017, Journal of advanced research.

[33]  R. V. van Breemen,et al.  Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  P. Ravi,et al.  Comparative pharmacokinetic evaluation of lopinavir and lopinavir‐loaded solid lipid nanoparticles in hepatic impaired rat model , 2017, The Journal of pharmacy and pharmacology.

[35]  Baochang Cai,et al.  Study on the Rationality for Antiviral Activity of Flos Lonicerae Japonicae-Fructus Forsythiae Herb Couple Preparations Improved by Chito-Oligosaccharide via Integral Pharmacokinetics , 2017, Molecules.

[36]  William A. Lee,et al.  Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.

[37]  Guangbo Ge,et al.  A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples. , 2016, Chemical communications.

[38]  Guangbo Ge,et al.  A Two-Photon Ratiometric Fluorescent Probe for Imaging Carboxylesterase 2 in Living Cells and Tissues. , 2015, ACS applied materials & interfaces.

[39]  Robert J Riley,et al.  Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modelling , 2015, Expert opinion on drug metabolism & toxicology.

[40]  Zhan-Qiu Yang,et al.  Antiviral activity of Folium isatidis derived extracts in vitro and in vivo. , 2013, The American journal of Chinese medicine.

[41]  Xinwen Wang,et al.  Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo , 2013, Acta Pharmacologica Sinica.

[42]  R. Thakur,et al.  Effect of Grapefruit Juice and Ritonavir on Pharmacokinetics of Lopinavir in Wistar Rats , 2012, Phytotherapy research : PTR.

[43]  K. Fung,et al.  Screening for Anti‐inflammatory and Bronchorelaxant Activities of 12 Commonly Used Chinese Herbal Medicines , 2012, Phytotherapy research : PTR.

[44]  M. Rheeders,et al.  Evidence for time-dependent interactions between ritonavir and lopinavir/ritonavir plasma levels following P-glycoprotein inhibition in Sprague-Dawley rats. , 2011, Biological & pharmaceutical bulletin.

[45]  G. Wallukat,et al.  Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids* , 2010, The Journal of Biological Chemistry.

[46]  G. Muirhead,et al.  Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers. , 2008, British journal of clinical pharmacology.

[47]  F. Akhlaghi,et al.  Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel , 2006, Journal of Pharmacology and Experimental Therapeutics.

[48]  A Joseph Layon,et al.  Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS. , 2006, The American journal of Chinese medicine.

[49]  D. Kempf,et al.  Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans , 2004, Pharmaceutical Research.

[50]  Jangsoon Kim,et al.  Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet's disease-like symptoms in mice and influences the expressions of cytokines. , 2003, International immunopharmacology.

[51]  D. Kroetz,et al.  Cytochrome P450 pathways of arachidonic acid metabolism , 2002, Current opinion in lipidology.

[52]  P. Hollenberg,et al.  The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[53]  P. Hollenberg,et al.  THE LICORICE ROOT DERIVED ISOFLAVAN GLABRIDIN INHIBITS THE ACTIVITIES OF HUMAN CYTOCHROME P 450 S 3 A 4 , 2 B 6 , AND 2 C 9 , 2002 .

[54]  R. Pollard,et al.  Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. , 1999, The American journal of Chinese medicine.